Neuca SA (NEU.WA) stock: key figures, P/E, revenue and dividend
Health Care · Poland · ISIN PLTRFRM00018
Neuca SA financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 12.61 bn PLN | 13.64 bn PLN |
| Gross profit | 1.44 bn PLN | 1.56 bn PLN |
| Operating income | – | 233.57 m PLN |
| EBIT | 275.00 m PLN | – |
| Net income | 154.00 m PLN | 155.58 m PLN |
| Diluted EPS – continuing operations | 34.01 PLN | 34.05 PLN |
Full history since 2001, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Neuca SA
NEUCA S.A. engages in the wholesale distribution of pharmaceuticals in Poland. It operates through Wholesale Distribution of Medicines, Manufacture of Pharmaceuticals, Medical Operator, Clinical Trials, and Insurance Activities segments. The company offers Rx, OTC drugs, dietary supplements, medical devices, dermocosmetics, hygiene products, personal protective equipment, as well as diagnostic and dressing materials under the Swiat Zdrowia, APTEO, GENOPTIM, CERA+ Solutions, and Kic Kic brands. It also provides medical care services, including prevention, diagnostics, treatment, and complementary services; and financing services, such as insurance, subscriptions, occupational medicine, preventive and medicine programmes, FFS, NFZ, public, private, and corporate payer services. In addition, the company offers TPA services, remote consultations, in person visits, diagnostic tests, and occupational medicine services; operates a medical helpline and medical facilities; and offers medicine through apteline.pl, an e-commerce medical ordering site. Further, it engages in running clinical trials in the field of outsourcing clinical research and conducting clinical research centres; provision of insurance products, including health insurance products. Additionally, the company provides advertising and marketing services to pharmaceutical market entities; and logistics services for pharmaceutical manufacturers. The company was formerly known as Torfarm SA and changed its name to NEUCA S.A. in April 2010. NEUCA S.A. was founded in 1990 and is based in Torun, Poland.
More stocks
- Bangkok Chain Hospital Public Company Limited (BCH.BK)
- Jiangsu Pacific Precision (300258.SZ)
- Piaggio & C SpA (PIA.MI)
- GemLife Communities Group (GLF.AX)
- Close Brothers Group PLC (CBG.L)
- Einhell Germany (EIN.DE)
- Foshan Saturday Shoes Co Ltd (002291.SZ)
- Dalian Insulator Group Co Ltd (002606.SZ)
- STURM RUGER & CO INC (RGR)
- Cryoport, Inc. (CYRX)
- HomeTrust Bancshares, Inc. (HTB)
- Allmed Medical Products Co Ltd Class A (002950.SZ)
Not investment advice. All data without warranty, price as of 02.11.2026. Details in the risk notice.